Review

Acquired antibiotic resistance of Pseudomonas spp., Escherichia coli and Acinetobacter spp. in the Western Balkans and Hungary with a One Health outlook

  • Received: 31 January 2025 Revised: 16 May 2025 Accepted: 22 May 2025 Published: 16 June 2025
  • An increasing rate of antibiotic resistance (AR) has been observed in the Gram-negative bacteria A. baumannii, P. aeruginosa, and E. coli in the human, environmental, and food animal domains worldwide, thus posing a serious global health challenge. Acquired AR genes of these species were overviewed from selected Western Balkans countries together with those from the European Union member states Croatia and Hungary. The AR determinants published from Albania, Bosnia-Herzegovina, Serbia, and Croatia included diverse acquired β-lactamase genes, with several of them possessing carbapenemase activity, such as blaVIM, blaNDM, blaKPC, blaOXA-23, blaOXA-66, and blaOXA-72. Furthermore, acquired aminoglycoside, chloramphenicol, fosfomycin, tetracycline, sulfonamide, quinolone, and/or colistin resistance determinants were detected in the three domains of the One Health approach. The in vitro AR profile of representative isolates have also been overviewed. Multidrug-resistant P. aeruginosa isolates of the ST235 high-risk clone were mainly reported within clinical settings. The distribution of the E. coli ST131 and A. baumannii ST2 high-risk clones in both clinical and environmental settings highlight their adaptability and effective dissemination. Systematic infection control practices are advised to combat the spread of antibiotic resistance, and further research from a One Health perspective is encouraged into its emergence and dissemination.

    Citation: Chioma Lilian Ozoaduche, Katalin Posta, Balázs Libisch, Ferenc Olasz. Acquired antibiotic resistance of Pseudomonas spp., Escherichia coli and Acinetobacter spp. in the Western Balkans and Hungary with a One Health outlook[J]. AIMS Microbiology, 2025, 11(2): 436-461. doi: 10.3934/microbiol.2025020

    Related Papers:

    [1] Ogueri Nwaiwu, Chiugo Claret Aduba . An in silico analysis of acquired antimicrobial resistance genes in Aeromonas plasmids. AIMS Microbiology, 2020, 6(1): 75-91. doi: 10.3934/microbiol.2020005
    [2] Amira ElBaradei, Dalia Ali Maharem, Ola Kader, Mustafa Kareem Ghareeb, Iman S. Naga . Fecal carriage of ESBL-producing Escherichia coli in Egyptian patients admitted to the Medical Research Institute hospital, Alexandria University. AIMS Microbiology, 2020, 6(4): 422-433. doi: 10.3934/microbiol.2020025
    [3] Oluwafolajimi Adesanya, Tolulope Oduselu, Oluwawapelumi Akin-Ajani, Olubusuyi M. Adewumi, Olusegun G. Ademowo . An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance. AIMS Microbiology, 2020, 6(3): 204-230. doi: 10.3934/microbiol.2020014
    [4] Rochelle Keet, Diane Rip . Listeria monocytogenes isolates from Western Cape, South Africa exhibit resistance to multiple antibiotics and contradicts certain global resistance patterns. AIMS Microbiology, 2021, 7(1): 40-58. doi: 10.3934/microbiol.2021004
    [5] Ana M. Castañeda-Meléndrez, José A. Magaña-Lizárraga, Marcela Martínez-Valenzuela, Aldo F. Clemente-Soto, Patricia C. García-Cervantes, Francisco Delgado-Vargas, Rodolfo Bernal-Reynaga . Genomic characterization of a multidrug-resistant uropathogenic Escherichia coli and evaluation of Echeveria plant extracts as antibacterials. AIMS Microbiology, 2024, 10(1): 41-61. doi: 10.3934/microbiol.2024003
    [6] Rosette Mansour, Mohammad H. El-Dakdouki, Sara Mina . Phylogenetic group distribution and antibiotic resistance of Escherichia coli isolates in aquatic environments of a highly populated area. AIMS Microbiology, 2024, 10(2): 340-362. doi: 10.3934/microbiol.2024018
    [7] Mohammad Abu-Sini, Mohammad A. Al-Kafaween, Rania M. Al-Groom, Abu Bakar Mohd Hilmi . Comparative in vitro activity of various antibiotic against planktonic and biofilm and the gene expression profile in Pseudomonas aeruginosa. AIMS Microbiology, 2023, 9(2): 313-331. doi: 10.3934/microbiol.2023017
    [8] Rania Abozahra, Amal Gaballah, Sarah M. Abdelhamid . Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt. AIMS Microbiology, 2023, 9(2): 177-194. doi: 10.3934/microbiol.2023011
    [9] Tsepo Ramatla, Mpho Tawana, Kgaugelo E. Lekota, Oriel Thekisoe . Antimicrobial resistance genes of Escherichia coli, a bacterium of “One Health” importance in South Africa: Systematic review and meta-analysis. AIMS Microbiology, 2023, 9(1): 75-89. doi: 10.3934/microbiol.2023005
    [10] Saboura Haghighi, Hamid Reza Goli . High prevalence of blaVEB, blaGES and blaPER genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa. AIMS Microbiology, 2022, 8(2): 153-166. doi: 10.3934/microbiol.2022013
  • An increasing rate of antibiotic resistance (AR) has been observed in the Gram-negative bacteria A. baumannii, P. aeruginosa, and E. coli in the human, environmental, and food animal domains worldwide, thus posing a serious global health challenge. Acquired AR genes of these species were overviewed from selected Western Balkans countries together with those from the European Union member states Croatia and Hungary. The AR determinants published from Albania, Bosnia-Herzegovina, Serbia, and Croatia included diverse acquired β-lactamase genes, with several of them possessing carbapenemase activity, such as blaVIM, blaNDM, blaKPC, blaOXA-23, blaOXA-66, and blaOXA-72. Furthermore, acquired aminoglycoside, chloramphenicol, fosfomycin, tetracycline, sulfonamide, quinolone, and/or colistin resistance determinants were detected in the three domains of the One Health approach. The in vitro AR profile of representative isolates have also been overviewed. Multidrug-resistant P. aeruginosa isolates of the ST235 high-risk clone were mainly reported within clinical settings. The distribution of the E. coli ST131 and A. baumannii ST2 high-risk clones in both clinical and environmental settings highlight their adaptability and effective dissemination. Systematic infection control practices are advised to combat the spread of antibiotic resistance, and further research from a One Health perspective is encouraged into its emergence and dissemination.



    Antibiotic resistance (AR) is an emerging global health challenge and one of the world's most serious threats today. Certain bacterial strains can acquire resistance to all (or nearly all) clinically used antibiotics, and Gram-negative bacteria make up the majority of the World Health Organization (WHO) priority list of antibiotic-resistant pathogens against which new treatments are needed [1]. AR is intimately linked to antibiotic usage, with drug abuse accelerating its emergence. Antibiotic abuse can take several forms, including unnecessary usage (as for example in non-bacterial diseases), excessive prescription (overuse), and poor antibiotic selection, dose, or duration [2].

    The high levels of AR for several important bacterial species–antibiotic group combinations reported by the European Antimicrobial Resistance Surveillance Network (EARS-Net) [2] for 2020 showed that AR is a serious threat to public health, both in the European Union/European Economic Area (EU/EEA) and worldwide [3]. It has been estimated that if new novel drugs are not discovered or formulated, there could be no effective antibiotics available to treat these resistant pathogens by 2050 [4].

    Escherichia coli is a major cause of bloodstream, intestinal, and urinary tract infections acquired in the community [5]. Antibiotics including ampicillin, amoxicillin/clavulanic acid, nitrofurantoin, fosfomycin, fluoroquinolones, cephalosporins, and trimethoprim/sulfamethoxazole have been found to cause high rates of resistance in uropathogenic E. coli strains [6]. Pseudomonas is a genus that is extensively found in both natural and aquatic habitats. Some of its species are opportunistic pathogens of humans and/or animals, while others can be harmful to plants [7]. These microbes can thrive in a wide range of environmental niches because of their metabolic versatility. Additionally, it has been well studied that the formation of biofilms in conjunction with antibiotic resistance may make it very challenging to eradicate Pseudomonas species from polluted environments or from illnesses in humans or animals [8]. Moreover, the presence of antibiotic-resistant P. aeruginosa has been found in wastewater treatment facilities [9]. The Acinetobacter species are known to cause a number of infections linked to healthcare [10], where Acinetobacter isolates from Southern and Eastern European countries, especially from the Balkans, can exhibit high rates of resistance to carbapenem antibiotics [10].

    Based on a report by the WHO Regional Office for Europe/European Centre for Disease Prevention and Control, the most common underlying factors that contribute to the problem of non-prudent and excessive empirical prescribing of antibiotics in hospitals include the lack of appropriately applicable clinical guidelines or prescribing protocols, not sufficient diagnostics and diagnostic uncertainty, inappropriate physicians' knowledge and prescribing autonomy, and the influence of other factors [2]. Some developing countries continue to employ antibiotics for growth promotion to maintain the healthy state of animals, to increase productivity, and to raise incomes for the farmers [11].

    Antibiotics have been widely utilized on dairy and other farms to prevent infections, where this kind of prophylaxis may be considered as a preventative group treatment for food animals [12]. However, Regulation (EU) 2019/6 of the European Parliament and of the Council on veterinary medicinal products (in force since 28 January 2022) states that antibiotic medicinal products should not be used for prophylaxis other than in exceptional cases and only for the administration to an individual animal [13]. On the one part, AR in bacteria may develop as a result of the usage of antibiotics in animals, with the potential to then spread to humans [14]. The overuse of antibiotics in poultry has been linked to a high degree of resistance in E. coli against therapeutically significant antibiotics such as penicillin, chloramphenicol, tetracycline, sulfonamides, and/or fluoroquinolones [15]. Additionally, airborne antibiotic-resistant bacteria and antibiotic resistance genes (ARGs) have been frequently detected on farms, and the abundance of some ARGs (such as tet, sul, erm, bla, mec, aac, van, mcr and mdr) in farm bioaerosols were reported [16].

    Antibiotics or ARGs can reach the environment through urinary and fecal excretions from humans and domestic animals, through direct environmental contamination in aquaculture or plant production, and via waste streams from the production of antibiotics or from hospitals [17]. The spread of acquired resistance in bacterial populations can be caused by a vertical spread with resistant clones (that is, clonal dissemination), by the relocation of the ARG to a genetic element that can independently move between cells, and by the horizontal transfer of mobile genetic elements (MGEs) [17].

    An increasing trend in the immigration into the Western Balkans region has been observed in the recent decade. Moreover, according to Eurostat, 23.8 million people (5.3%) of the 446.7 million people living in the EU on 1 January 2022 were non-EU citizens [18]. Tourism, the employment of non-EU citizens, and industrial and economic connections (e.g., Hungarian-owned-businesses in Western Balkans countries such as Croatia, Serbia) can also facilitate the dissemination of antimicrobial resistant bacterial strains and, in turn, affect public health in this region of Europe. The Western Balkans, known for their magnificent and diverse geographical regions, provide a great variety of habitats to support a wide range of natural and human impacted ecosystems [19]. Among these habitats, resistant bacteria of human and veterinary origins may be disseminated, in part, by migratory birds with contaminated food or water, and birds can also play a role in the ecology, circulation, and dissemination of antibiotic-resistant bacteria through their fecal depositions [20][22].

    The aim of this review is to analyze and summarize vailable reports of antibiotic resistance determinants in selected counties of the Western Balkans region (Albania, Bosnia-Herzegovina, Serbia and Croatia) with a One-Health outlook, and to examine potential relationships with those from the neighboring EU member state Hungary.

    Multidrug resistance refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of multiple antimicrobial agents, where a bacterial isolate is considered multidrug-resistant (MDR) if the isolate is non-susceptible to at least one agent in ≥3 antimicrobial categories [23],[24]. Some of the mechanisms that might contribute to the MDR phenotype include genetic mutations which lead to the development of resistance to antibiotics, horizontal gene transfer, the exchange of genetic material between microorganisms, efflux pumps that can remove antibiotics from the cell, the appearance of novel enzymes or enzyme modifications that can degrade a particular antibiotic, biofilm development (i.e., complex communities of microorganisms adhered to surfaces and more resistant to antibiotics), and various mechanisms for the alterations of antibiotics [17],[24]. The in vitro AR profiles of representative isolates discussed in this review are available in Supplementary Table 1.

    Some examples of high-risk MDR bacteria include extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, MDR P. aeruginosa, and carbapenem-resistant Enterobacteriaceae (CRE) [23],[24].

    The population of the whole world, including the Western Balkans region, faces significant challenges of bacterial multidrug resistance [3],[23]. Studies have shown that the Western Balkans region also has a high prevalence of MDR bacteria [10],[25],[26]. Several factors can contribute to this high prevalence, including the overuse and misuse of antibiotics, a lack of effective infection control measures, insufficient surveillance and monitoring, and economic constraints and limited resources [2],[23],[24],[27].

    Widespread elevated morbidity and mortality, financial hardships, and compromised antibiotic efficacy can be some of the outcomes of bacterial multidrug-resistance in the Western Balkans [3],[23][26]. The spread of ARGs in the human and animal populations increases the likelihood of disease transmission, reduces the efficacy of antibiotic treatments, and might also have serious economic consequences for animal husbandry, including a decreased output and higher costs [11],[12],[23],[24].

    Additionally, the presence of these potent acquired (and thus transferable) ARGs in the environment has the potential to pollute water and soil, which puts human and animal health at risk. Thus, the widespread distribution of such ARGs can potentially have a substantial influence both on agricultural and natural ecosystems, including the disruption of microbial populations and a reduction of microbial biodiversity [11],[12],[23],[24].

    In Serbia, Lepsanovic et al. [28] first reported an ST235 P. aeruginosa clinical isolate that carried a blaVIM-2-like metallo-β-lactamase gene. A PER-1 ESBL producing serotype O11 P. aeruginosa strain from a Serbian clinical setting also possessed an aacA4 aminoglycoside acetyltransferase, aadB and aadA2 aminoglycoside adenyltransferases, an aphA aminoglycoside phosphotransferase, and blaOXA2 resistance genes [29]. Jovcic and colleagues in 2011 and 2014 [30],[31] described the globally significant blaNDM-1 metallo-β-lactamase determinant in P. aeruginosa in Serbia. Moreover, studies by Kabic et al. revealed the occurrence of blaNDM-1, blaGES-5, blaPER1, blaOXA-396, and blaOXA-488 β-lactamases, aadA6 aminoglycoside adenyltransferase, aphA6, aph(3)-IIb, aph(6)Id, and aph(6)Ib aminoglycoside phosphotransferases, and the sul1 sulfonamide resistance gene in P. aeruginosa in Serbia [32]. Several potent ARGs were also identified in A. baumannii in Serbia by Kabic and coworkers [33]. The resistance genes blaNDM-1, blaOXA-488, aac(6′)-Il, aph(3′)-IIb, ant(2″)-Ia, sul1, fosA, and catB7 were described in P. aeruginosa from Albania [34]. Additionally, acquired metallo-β-lactamases and other acquired resistance genes of P. aeruginosa, E. coli, and A. baumannii were also reported in the European Union (EU) member state Croatia, as summarized in Table 1 [28][44].

    Acquired ARGs of E. coli have been characterized from some food animals in the Western Balkan [45], including mcr-1, blaTEM-1B, blaCTX-M-1, aac(3)-IId, aph(30)-Ia, aadA5, sul2, and catA1 genes from pigs in Croatia (see Table 2).

    Table 1.  Acquired antimicrobial resistance genes in the clinical setting in the Western Balkans.
    Location Resistance genes Sequence Type (Serotype) References
    Serbia
    P. aeruginosa
    Belgrade blaVIM-2-like ST235 (O11) [28]
    Belgrade blaPER-1, blaOXA-2, aacA4, aadA2, aadB, aphA ST235 (O11) [29]
    Belgrade blaNDM-1 N/A [30],[31]
    Belgrade, Kragujevac, Sombor blaNDM-1, blaPER-1, blaGES-5, blaOXA-396, blaOXA-488, aadA6, aphA6, aph(3′)-IIb, aph(6′)Id, aph(6′)Ib, sul1, qac ST235, ST654 [32]
    A. baumannii
    N/A blaOXA-72, blaOXA-66, blaADC-25, aadA2, aphA6, armA, tetB, sul1, sul2, strA, strB, dfrA12 ST492 [35]
    Belgrade, Vojvodina blaOXA-66/blaOXA-23, blaADC-73, blaADC-217 ST2 [33]
    Belgrade, Vojvodina blaNDM-1, blaOXA-72, blaADC-30, aac(3′)-Ia, aadA, aadA2, aph(3′)-Ia, aph(3′)-VI, sul2, drfA1, dfrA12, catI ST492 [33]
    Belgrade, Vojvodina blaOXA-72, blaADC-74, aac(3)-Ia, aadA, aph(3′)-Ia ST636 [33]
    Belgrade blaOXA-66/blaOXA-72 ST636 [36]
    Albania
    P. aeruginosa
    N/A blaNDM-1, blaOXA-488, blaPAO, aac(6′)-Il, aph(3′)-IIb, ant(2″)-Ia, sul1, fosA, catB7, crpP ST235 [34]
    A. baumannii
    N/A blaTEM-1, blaOXA-23, blaOXA-51, ampC, aph(3′)-Ia, aphA6, armA, tetB, sul2, strA, strB ST2/ST436 [37]
    Croatia
    P. aeruginosa
    Dalmatia blaVIM-2, blaOXA-10 ST235 (O11) and ST111 (O12) [38]
    Zagreb, Dalmatia blaVIM-1, blaVIM-2, blaPER-1, blaGES-7 ST235 (O11), ST111 (O12) [39]
    E. coli
    Dubrovnik, Zagreb, Slavonski Brod blaCTX-M-27, blaCTX-M-15, blaCTX-M-55, blaTEM-1, blaOXA-1, aadA2, aadA5, aac(6′)Ib-cr, aac(3)-IIa, tet(A), sul1, sul2, strA, strB, fosA, catB3, dfrA12, mph(A) ST131 [40]
    Zagreb blaCTX-M, blaOXA-48 N/A [41]
    A. baumannii
    Osijek blaOXA-23, blaOXA-66, blaADC-25, aac(3)-Ia, aadA1, aph(3′)-VIa, aph(3″)-Ib, aph(6)-Id, armA, tet(B), sul1 N/A [42]
    Zagreb blaOXA-23 N/A [41]
    Bosnia and Herzegovina
    A. baumannii
    Mostar blaOXA-23-like, blaOXA-40-like, blaOXA-51-like, blaOXA-69, blaOXA-72, blaADC, aac(3)-Ia, aadA1, sul1 ST642, ST636 [43]
    E. coli
    Zenica-Doboj Canton blaCTX-M-1, blaCTX-M-3, blaCTX-M-15, blaSHV-1, blaSHV-5, blaCMY-2 N/A [44]

     | Show Table
    DownLoad: CSV
    Table 2.  Acquired antimicrobial resistance genes in food animals in the Western Balkans.
    Sample type (Location) Resistance Genes Sequence type (Serotype) References
    Croatia
    E. coli
    Pigs (N/A) blaCTX-M-1, blaTEM-1B, aac(3)-IId, aadA5, aph(3′)-Ia, sul2, mcr-1, catA1 ST744 [45]

     | Show Table
    DownLoad: CSV

    In Croatia, blaTEM-116 ESBL was detected in Pseudomonas spp. and in E. coli by Maravic et al. (2012) and Puljko et al. (2023) from coastal waters and hospital wastewater, respectively [46],[47]. Carbapenemase producing isolates were also described from wastewater treatment plant and dump site environmental samples [48][50]. Aminoglycoside acetyltransferase (aac), adenyltransferase (aad), phosphotransferase (aph) genes, and other types of ARGs were identified in Acinetobacter spp. by Higgins and coworkers [50] (Table 3). Cirkovic and colleagues identified antibiotic resistant P. aeruginosa, E. coli, and A. baumannii from wastewater in Belgrade [51]. Velhner and colleagues [52] reported blaCTX-M-1, blaTEM-1, blaCMY-2, aadA1, tet(A), tet(B), sul1, sul2, sul3, strA, strB, cat1, dfrA1, dfrA7/17, and dfrA12 resistance determinants from black-headed gulls in Serbia.

    Table 3.  Acquired antimicrobial resistance genes in the environment in the Western Balkans.
    Sample type (Location) Resistance Genes Sequence Type (Serotype) References
    Croatia
    P. fluorescens
    Coastal waters (Kaštela) blaTEM-116 N/A [46]
    E. coli
    Hospital wastewater (Zagreb) blaCTX-M-15/blaTEM-116, blaTEM-1, blaKPC-2 ST131 [47]
    A. baumannii
    Wastewater treatment plant (Zagreb) blaOXA-23-like, blaOXA-40-like, blaOXA-51-like N/A [48]
    Dump site (Rijeka) blaOXA23, blaOXA72 ST195, ST231 [49]
    Wastewater treatment plant (Zagreb) blaOXA-23, blaOXA-66, aac(3)-Ia-like, aadA1, aph(3′)-VIa-like, armA, tet(B)-like, sul1, strA, strB, catA1-like ST195/ST2 [50]
    Serbia
    P. aeruginosa
    Wastewater (Belgrade) blaPER-1, blaOXA-395, blaOXA-847, aph(3″)-Ib, aph(3′)-IIb, aph(3′)-VIb, aph(6)-Id, crpP, catB7, fosA ST348, ST2305 [51]
    E. coli
    Black-headed gulls (Novi Sad) blaCTX-M-1, blaTEM-1, blaCMY-2, aadA1, tet(A), tet(B), sul1, sul2, sul3, strA, strB, cat1, dfrA1, dfrA7/17, dfrA12 ST38 [52]
    Wastewater (Belgrade) blaNDM-1, blaOXA-1, blaSHV-12, blaTEM-1, blaOXA-10, blaOXA-48, aac(3)-IIe, aac(3)-IId, aac(3)-IIg, aac(6′)-Ib, aac(6′)-Ib-cr5, aac(6′)-Ib4, aac(6′)-IIc, aadA2, aph(3′)-Ia, aph(3′)-VI, aph(3″)-Ib, aph(6)-Id, tet(D), tet(B), sul1, sul2, catA1, catB3, dfrA12, dfrA14, qnrA6, catB3, cmlA5 ST1133/ST1970, ST21/ST155, ST43/ST131 [51]
    A. baumannii
    Wastewater (Belgrade) blaOXA-23, blaOXA-66, blaOXA-72, aadA2, abaF, ant(3″)-IIa, aph(3″)-Ib, aph(3″)-Ib, aph(6)-Id, armA, tet(B), sul1, sul2, dfrA12 ST2/ST195, ST492/ST425 [51]

     | Show Table
    DownLoad: CSV

    A great variety of antibiotic resistance genes have been identified in the clinical setting in Hungary, including ESBLs, and aminoglycoside, tetracycline, and sulfonamide resistance genes; see Table 4 for examples [53][62]. blaVIM-4 metallo-β-lactamase-producing P. aeruginosa clinical isolates characterized in Hungary included serotype O11 or O12 isolates in Budapest, Pécs, Mosonmagyaróvár, and other locations [53],[54]. The observations of recovering the same class 1 integron from different serotypes of P. aeruginosa from different locations indicated a role for a horizontal transfer in its dissemination and/or the repeated acquisition of this integron by various clinical strains [54]. P. aeruginosa clinical isolates that carried the aminoglycoside adenyltransferase genes aadA13 and aadB with serotype O4 and ST175 were detected in Budapest, Gyula, Dombóvár, Veszprém, Balassagyarmat, Zalaegerszeg, and Szolnok, as well as an aadB determinant with serotype O6 and ST395 in Budapest, Miskolc, Debrecen, Székesfehérvár, and Pápa. This suggested that integrons may effectively contribute to the clonal dissemination of aminoglycoside resistance, which was likely due to the movement of infected or colonized individuals across different epidemiological settings [56]. Twelve human GenR E. coli strains and thirty-eight GenR E. coli strains of a food animal origin were examined and identified in Hungary with multidrug resistance, which led to the conclusion that the treatment of E. coli infections in humans and animals may be increasingly constrained by resistance genes in commensal and clinical strains [58]. Szmolka et al. (2012), Tóth et al. (2013), Nagy et al. (2023), and Gulyás et al. (2023) characterized E. coli clinical isolates that harbored blaCTX-M-type ESBL genes: blaCTX-M-1 [58][60] and blaCTX-M-15 [59][61]. The carbapenemase determinants blaOXA-23 and blaOXA-72 were identified in ST636 and ST492 A. baumannii [62].

    blaCTX-M, blaSHV, and blaTEM-type β-lactamases have been identified in E. coli isolated from poultry, pigs, and cattle [58],[59]. Pigs and poultry were both shown to carry aminoglycoside adenyltransferases and tetracycline resistance genes aadA and tet(A) [63],[64]. Intestinal E. coli strains of food animals such as pigs, chickens, and red deer possessed aminoglycoside acetyltransferases, aminoglycoside phosphotransferases, β-lactamases, and tetracycline resistance genes [64]. Food producing animals such as domestic pigs and chickens harbored blaTEM-1B, blaCMY-2, aac(3)-VIa, aadA1, tet(A), tet(B), tet(C), sul1, sul2, strA, and strB resistance genes [64],[65].

    Acquired β-lactamases, aminoglycoside acetyltransferases, aminoglycoside adenyltransferases, aminoglycoside phosphotransferases, sulfonamide, and tetracycline resistance genes were repeatedly identified in other studies from food animals, as shown in Table 5 [58],[59],[63][66].

    Table 4.  Acquired antimicrobial resistance genes in the clinical setting in Hungary.
    Hungarian clinical setting
    Location Resistance Genes Sequence Type (Serotype) References
    P. aeruginosa
    Pécs blaVIM-4, aacA4 ST229 (O12) [53],[54]
    Győr blaVIM-4, blaOXA-2, aacA7, aacA8 ST235 (O11) [53],[54]
    Budapest blaPER-1, blaOXA-2, blaOXA-74, aac(6′)-Ib-cr, cmlA7 ST235 (O11) [29]
    Budapest blaVIM-2, blaVIM-4, aacA4, aacA7 ST313 (O1), ST111 (O12), ST229 (O12) [53],[54]
    Budapest blaVIM-2, blaPER-1 N/A [55]
    Gyula blaVIM-4, aacA4 ST235 (O11) [54]
    Budapest aadA13, aadB ST175 (O4), ST395 (O6) [56]
    Gyula aadA13, aadB ST175 (O4) [56]
    Dombóvár aadA13, aadB ST175 (O4) [56]
    Veszprém aadA13, aadB ST175 (O4) [56]
    Balassagyarmat aadA13, aadB ST175 (O4) [56]
    Szolnok aadA13, aadB ST175 (O4) [56]
    Miskolc aadB ST395 (O6) [56]
    Debrecen aadB ST395 (O6) [56]
    Székesfehérvár aadB ST395 (O6) [56]
    Pápa aadB ST395 (O6) [56]
    6 diagnostic centres blaNDM, blaVIM, blaIMP, blaKPC, blaOXA-48-like N/A [57]
    E. coli
    N/A blaCTX-M-1, blaSHV, blaTEM, blaOXA-1, aac(6′)-Ib, aadA1-like, aadA4-like, ant(2″)-Ia, tet(A), tet(B), sul1, sul2, strA, strB, catA1, catB3-like, floR, dfrA1, dfrA17 N/A [58]
    N/A blaCTX-M-1, blaCTX-M-15, blaSHV-2, blaSHV-5, blaSHV-12, blaTEM-1 ST131 (O25), (O15) [59]
    South-Pest blaCTX-M-1, blaCTX-M-15, acc(6′)-lb-cr, tet(A), sul1, dfrA17 ST43 (H4-O25) [60]
    Budapest blaNDM-5, blaCTX-M-15, blaTEM-1B, blaOXA-1, blaOXA-181, blaCMY-2, aac(6′)-Ib-cr, aadA2, aadA5, dfrA5, dfrA12, dfrA17, sul1, mdf(A), mph(A), erm(B), catB3, tet(B), qnrS13 ST410 [61]
    A. baumannii
    N/A blaPER-1 N/A [55]
    N/A blaOXA-23, blaOXA-72 ST636, ST492 [62]

     | Show Table
    DownLoad: CSV
    Table 5.  Acquired antimicrobial resistance genes in the food/animal setting in Hungary.
    Hungarian food/animal setting
    Sample type (Location) Resistance Genes Sequence Type (Serotype) References
    E. coli
    Poultry (N/A) blaTEM, aadA1-like, aadA2-like, aadA4-like, tet(A), tet(B), sul1, sul2, strA, strB, catA1, floR, dfrA1, dfrA12, dfrA17, dfrA19 N/A [58]
    Pigs (N/A) blaTEM, aadA1-like, aadA2-like, aadA4-like, tet(A), tet(B), sul1, sul2, sul3, strA, strB, catA1, floR, cmlA1-like, dfrA12, dfrA14, dfrA17, dfrA19, dfrV N/A [58]
    Cattles (N/A) blaCTX-M-1, blaSHV, blaTEM, blaOXA-1, aadA1-like, aadA2-like, aadA4-like, tet(A), tet(B), sul1, sul2, sul3, strA, strB, catA1, floR, dfrA1, dfrA14, dfrA15, dfrA17 N/A [58]
    Poultry, cattle or milk, pig (N/A) blaCTX-M-1, blaCTX-M-32, blaSHV-2, blaTEM-1 (O162, O8) [59]
    Pigs (Pécs) aadA, tet(A), strA (O141) [63]
    Domestic pig (Herceghalom) aadA1, tet(A), tet(B) N/A [64]
    Chicken (Herceghalom) blaTEM-1B, blaCMY-2, aac(3)-VIa, aadA1, tet(A), sul1, sul2, strA, strB N/A, E. coli strain K1G [64]
    Pigs (Herceghalom) tet(C) N/A [65]
    Duck (N/A) mcr-1 ST162 [66]

     | Show Table
    DownLoad: CSV

    A great variety of ARGs were identified in the environmental setting in Hungary, as exemplified in Table 6 [61],[64],[67], including β-lactamases with a carbapenemase activity (such as blaNDM-1, blaNDM-5, blaVIM-4), aminoglycoside acetyltransferases, aminoglycoside adenyltransferases, aminoglycoside phosphotransferases, tetracycline, and sulfonamide resistance genes. The β-lactamase genes blaNDM-1, blaVIM-4, blaSHV-12, blaTEM-1, and blaOXA-10 were identified in the river Danube and black-headed gulls in Hungary [61]. Other determinants recovered from both the Danube and black-headed gulls included aac(3′)-lld, aac(6′)-IIa, aac(6′)-Ib-cr, aadA1, aadA2, aadA5, aph(3′)-VI, aph(3″)-Ib, and aph(6)-Id [61]. The tet(A), tet(B), and sul1 genes were identified from both environmental sources (Table 6). tet(B), strA, and strB resistance genes were detected from free-living red deer in Zsitfapuszta and Vörösalma in South-West Hungary [64]. The fallow deer and red deer samples were considered as environmental samples because these were free-living animals in their natural environmental habitat.

    Table 6.  Acquired antimicrobial resistance genes in the environmental setting in Hungary.
    Hungarian environmental setting
    Sample type (Location) Resistance Genes Sequence Type (Serotype) References
    E. coli
    Danube (Budapest) blaNDM-1, blaVIM-4, blaSHV-12, blaTEM-1, blaOXA-10, blaCARB-12, aac(6′)-Ib-cr, aac(6′)-IIa, aadA1, aadA5, ant(2″)-Ia, aph(3′)-VI, aph(6)-Id, aph(3″)-Ib, tet(A), sul1, sul2, catA1, floR, dfrA1, dfrA7, dfrA14, mdf(A), mph(A), mph(B) ST10 [61]
    Danube (Budapest) blaNDM-1, blaCTX-M-24, blaTEM-1, blaOXA-9, blaOXA-10, aac(6′)-Ib-cr, aac(6′)-IIa, aadA1, aph(3′)-VI, ant(3″)-Ia, dfrA14, sul1, mdf(A), mph(A), erm(42) ST354 [61]
    Danube (Budapest) blaNDM-5, blaCTX-M-15, blaTEM-1B, blaCMY-2, blaOXA-1, aac(3)-IId, aac(6′)-Ib-cr, aadA2, aadA5, aph(6)-Id, aph(3″)-Ib, tet(B), sul1, sul2, catB3, dfrA12, dfrA17, mph(A), mdf(A) ST410 [61]
    Black-headed gulls (Budapest) blaNDM-1, blaVIM-4, blaTEM-1B, blaOXA-10, aac(3′)-lld, aac(6′)-IIa, aac(6′)-Ib-cr, aadA1, aadA2, aph(3′)-VI, aph(3′)-I, tet(A), sul1, sul3, cmlA1, dfrA1, dfrA12, dfrA14, mdf(A), erm(42), mph(A) ST224 [61]
    Black-headed gulls (Budapest) blaOXA-181, blaDHA-1, sul1, dfrA17, qnrB4, qnrS1 ST372 [61]
    Black-headed gulls (Budapest) blaNDM-1, blaSHV-12, blaTEM-1B, blaOXA-10, blaCMY-4, blaCMY-16, aac(3′)-lld, aadA1, aadA5, aph(3′)-VI, aph(3′)-Ia, aph(3″)-Ib, aph(6)-Id, rmtC, tet(A), tet(B), tet(D), sul1, sul2, fosL1, cmlA1, catA1, floR, dfrA14, dfrA17, qnrA1, qnrB19, mdf(A), mph(A) ST744 [61]
    Fallow deer, red deer (Zsitfapuszta) tet(A), tet(B), strA, strB [64]
    Red deer (Vörösalma) tet(B), strA, strB [64]
    Wild boar (Zemplén) acrD ST388 (O112ab:H2) [67]

     | Show Table
    DownLoad: CSV

    MDR P. aeruginosa and A. baumannii isolates resistant to multiple agents can leave limited antimicrobial treatment options for clinicians. P. aeruginosa possesses several chromosomally encoded efflux pumps that can remove antimicrobial agents from the cell, thus reducing their effectiveness. At the same time, various acquired β-lactamases can be produced, such as VIM, IMP, and GES-type enzymes [68]. In general, MDR Gram-negative bacteria can produce a variety of acquired enzymes that modify aminoglycosides and other type of antibiotics, thus rendering them ineffective. Additionally, biofilm formation can protect these pathogens from antimicrobial agents and host immune responses [69]. Patients with cystic fibrosis or with compromised immune systems, such as those with HIV/AIDS or undergoing chemotherapy, are at an increased risk of developing MDR P. aeruginosa or other nosocomial infections [70].

    MDR E. coli resistant to multiple antimicrobial agents can emerge by the production of β-lactamases, including CTX-M, SHV, and TEM-types, and by acquiring several other ARGs through a horizontal transfer [71]. Additionally, the spread of MDR E. coli can be facilitated besides other means by international travel and trade, which can introduce resistant strains into new regions by human and animal carriers. MDR E. coli can also cause community-onset infections such as urinary and intestinal tract infections [4]. MDR A. baumannii strains producing efflux pumps and/or various β-lactamases, such as OXA-23, OXA-24, and OXA-58 [72],[73], are often isolated from trauma patients, particularly those with combat-related injuries, and are a common cause of ventilator-associated pneumonia (VAP) in Intensive Care Units [73]. The WHO prioritized MDR A. baumannii, P. aeruginosa, and Enterobacteriaceae (e.g., K. pneumonia, E. coli) as critical cases of antibiotic-resistant bacteria. These Gram-negative pathogens can harbor potent carbapenemase-encoding genes, which enable the inactivation of most β-lactam antibiotics [74].

    The first report of the New Delhi metallo-β-lactamase (encoded by blaNDM), which confers resistance to a broad range of β-lactam antibiotics, was first published in 2009, where it was described in a Klebsiella pneumoniae isolate from a Swedish patient of Indian origin [75]. Subsequently, the blaNDM-1 gene was globally identified, including within the Balkans region. It was detected in clinical isolates of P. aeruginosa, E. coli, and Acinetobacter sp. in Serbia, a clinical P. aeruginosa isolate in Albania, and from E. coli isolates recovered from food animals and from environmental samples in Hungary (see Figure 1). Thus, this acquired carbapenemase has already been observed in several countries of this region of Europe and in all three domains of the One Health principles, thus highlighting the efficiency of its spread among Gram-negative bacteria.

    P. aeruginosa isolates that belong to the sequence type 235 (ST235), an international high-risk clone that has the potential to cause nosocomial outbreaks with poor clinical outcomes, are a cause of serious concern; it is estimated that the ST235 sublineage emerged in Europe around 1984 and has successfully spread globally since then [34]. Metallo-β-lactamase-producing P. aeruginosa strains are linked to increased case fatality rates and invasive illnesses [54]. The blaVIM metallo-β-lactamase genes encode another type of widespread carbapenemase enzyme, which was identified in clinical P. aeruginosa isolates in Serbia, Croatia, and Hungary. VIM-4-producing ST235 P. aeruginosa clinical isolates were reported from Budapest and Gyula in Hungary [53],[54], VIM-2-like producing clinical ST235 P. aeruginosa from Belgrade, Serbia [53],[54], and metallo-β-lactamase producing clinical ST235 P. aeruginosa isolates from Croatia [38] and Albania [34]. PER-1 ESBL positive clinical ST235 P. aeruginosa was reported from Budapest, Hungary. and Belgrade, Serbia [29]. These observations about the role of ST235 clinical isolates in disseminating high-risk antibiotic resistance determinants can be put into a wider context by considering their recovery from environmental samplings from hospital effluents/wastewaters in Germany and Brazil [76],[77]. Furthermore, ST235 P. aeruginosa strains were cultured from dogs and cats in Thailand, and carbapenem-resistant ST235 P. aeruginosa from dogs and cats in Japan [78],[79]. Overall, these findings highlight the necessity of a comprehensive One Health approach that includes samples from humans, animals, and their environment in uncovering possible routes of dissemination of such high-rick international clones of MDR Gram-negative bacteria.

    Figure 1.  The distribution of various acquired β-lactamaseses in Hungary and in selected Western Balkans countries. Black, blue and red characters indicate enzymes reported for P. aeruginosa, E. coli and A. baumanii isolates, respectively.

    Other resistance genes including acquired β-lactamases, aminoglycoside acetyltransferases, aminoglycoside adenyltransferases, aminoglycoside phosphotransferases, and sulfonamide resistance genes were identified in clinical, food animal, and environmental samples in the Western Balkans. The resistance gene blaCMY-2 identified in E. coli from free-living wild animals in Serbia was also identified in Hungary in E. coli strain K1G isolated from broiler chicken [64]. As shown in Tables 2 and 6, ST744 E. coli harbored blaTEM-1B, aac(3′)-lld, aadA5, aph(3′)-Ia, sul2, and catA1 resistance genes in both pigs and gulls from Croatia and Hungary, respectively. Likewise, ST2 A. baumannii that carried the carbapenemase variants blaOXA-23 and blaOXA-66 was identified in a Serbian clinical setting, in Serbian wastewater, and in a Croatian wastewater treatment plant (Figure 1, Tables 1 and 3). From a One Health perspective, it should be highlighted that OXA-66- and OXA-72-coproducing ST2 A. baumannii was identified from an organic baby leaf mix purchased from a retail shop in Japan [80], which is similar to the ST2 A. baumannii found in Serbian wastewater [51] (Table 3). In addition, carbapenem-resistant ST2 A. baumannii with a blaOXA23-like gene was obtained from a two-year-old domestic cat in Pakistan [81], which is similar to clinical isolates from Serbia and Albania, and wastewater isolates from Croatia and Serbia (Tables 1 and 3). The most globally widespread high-risk clone and the most significant Acinetobacter species that infect humans is the ST2 carbapenem-resistant A. baumannii [51]. Additionally, it was noted that OXA-72-producing A. baumannii ST636 has been detected in clinical settings in Bosnia, Hungary, and Serbia (Tables 1 and 4).

    Our findings highlight the detection of ST131 E. coli that harbors the β-lactamase variants blaCTX-M-15 and/or blaTEM-1 in the clinical setting of Croatia and Hungary, as well as in Croatian hospital wastewater and sewer outlets wastewater in Serbia (Figure 1, Tables 1, 3 and 4). ST131 E. coli which carried blaCTX-M-15 has also been reported from clinical samples of a Tanzanian tertiary hospital [82], diarrheic poultry in Tunisia [83], and from a Glaucous-winged gull in Russia [84]. A comprehensive multinational European investigation indicated that 6% of ESBL-producing E. coli, which was isolated from diverse companion animals, were classified as E. coli ST131, and the infrequent presence of E. coli ST131 supports the concept that humans, rather than companion or food-producing animals, are the principal reservoir of this high-risk clone [83]. ESBLs are predominant enzymes that can degrade cefotaxime, and the blaCTX-M-15 variant is considered to be globally dominant [82]. ST131-O25b-B2 E. coli is a prominent cause of serious human extraintestinal infections, particularly community-acquired urinary tract infections; it has also been observed in companion and non-companion animals that have had human contacts [83]. CTX-M-15-producing ST131 E. coli detected in wild birds was proposed to be of a human origin, with a potential of clonal dissemination even into environments lacking antibiotic pressure [84].

    Our review underscores the significant contribution of high-risk clones to the global spread of antibiotic resistance. Notably, ST235 in P. aeruginosa, ST131 in E. coli, and ST2 in A. baumannii have emerged as prominent examples of high-risk global clones, exhibiting a widespread distribution in clinical settings, wastewater, and animals, thereby emphasizing the need for targeted surveillance and intervention strategies.

    Based on the main findings of this literature review, a high variety of ESBLs and carbapenem resistance mechanisms were demonstrated in bacteria identified from the Western Balkans countries, alongside strains from Hungary (Tables 47). The dissemination of multidrug-resistant Gram-negative pathogens is considered a serious public health issue, both in this region of Europe as well as globally [85]. The One Health approach recognizes the interconnection and mutual influence of its three domains, and their interconnections create pathways by the clonal transmission of bacteria and by mobile genetic elements (MGEs) [74],[86][89].

    Table 7.  ARGs in Hungary and Western Balkans countries of study.
    AR Class Bacterial Strain Country AR genes
    Quinolone E. coli Serbia qnrA6
    Hungary qnrS13, qnrB4, qnrA1, qnrB19, qnrS1
    Tetracycline E. coli Hungary tetA, tetB, tetD
    Serbia tetA, tetB, tetD
    Croatia tetA
    A. baumannii Serbia tetB
    Albania tetB
    Croatia tetB
    Phenicol P. aeruginosa Hungary cmlA7
    Serbia catB7
    Albania catB7
    E. coli Hungary catA1, catB3, floR, cmlA1
    Serbia catA1, catB3, cmlA5
    Croatia catA1, catB3
    A. baumannii Serbia catI
    Croatia catA1
    Aminoglycoside P. aeruginosa Hungary aacA4, aacA7, aacA8, aac(6′)-Ib-cr, aadA13, aadB
    Serbia aacA4, aadA2, aadB, aadA6, aphA6, aph(3′)-IIb, aph(6′)Id, aph(6′)Ib, aph(3″)-Ib, aph(3′)-IIb, aph(3′)-VIb, aph(6)-Id
    Albania aac(6′)-Il, aph(3′)-IIb, ant(2″)-Ia, aph(3′)-Ia, aphA6, armA, strA, strB
    E. coli Hungary aac(6′)-Ib, ant(2″)-Ia, aac(3)-lld, aac(6′)-Ia, aac(6′)-Ib-cr, aadA1, aadA2, aadA4-like, aadA5, aph(3′)-VI, aph(3′)-I, aac(3)-VIa, aadA1, aph(3″)-Ib, aph(6)-Id, aac(3)-Id, aac(6′)-IIa, strB, strA
    Serbia aadA1, aac(3)-IIe, aac(3)-IId, aac(3)-IIg, aac(6′)-Ib, aac(6′)-Ib-cr5, aac(6′)-Ib4, aac(6′)-IIc, aadA2, aph(3′)-Ia, aph(3′)-VI, aph(3″)-Ib, aph(6)-Id, strA, strB
    Croatia aadA2, aadA5, aac(3)-IId, aadA5, aph(3′)-Ia, aadA2, aac(6′)Ib-cr, aac(3)-IIa, strA, strB
    A. baumannii Serbia aadA2, aphA6, aac(3′)-Ia, aph(3′)-Ia, aph(3′)-VI, aac(3)-Ia, aadA, aph(3′)-Ia, abaF, ant(3″)-IIa, aph(3″)-Ib, aph(6)-Id, armA, strA, strB
    Croatia aadA1, aac(3)-Ia, aph(3′)-VIa, aph(3″)-Ib, aph(6)-Id, aph(3′)-Ia, aac(3)-IId, aadA5, aac(3)-Ia-like, aph(3′)-VIa-like, armA, strA, strB
    Bosnia and Herzegovina aac(3)-Ia, aadA1
    Macrolide E. coli Hungary ermB, erm42
    Sulphonamide P. aeruginosa Serbia sul1
    Albania sul1
    A. baumannii Serbia sul1, sul2
    Albania sul2
    Croatia sul1
    Bosnia and Herzegovina su1
    E. coli Serbia sul1, sul2, sul3
    Croatia sul1, sul2
    Hungary sul1, sul2, sul3
    Colistin E. coli Croatia mcr-1
    Hungary mcr-1
    Trimethoprim A. baumannii Serbia dfrA12
    E. coli Serbia dfrA1, dfrA7/17, dfrA12, dfrA14
    Hungary dfrA1, dfrA5, dfrA12, dfrA14, dfrA15, dfrA17, dfrA19, dfrV
    Croatia dfrA12
    β-lactam P. aeruginosa Hungary blaVIM-4, blaOXA-2, blaVIM-2, blaPER-1, blaOXA-74, blaOXA-48-like, blaNDM, blaVIM, blaIMP, blaKPC
    Serbia blaNDM-1, blaVIM-2-like, blaPER-1, blaOXA2, blaGES-5, blaOXA-396, blaOXA-488, blaOXA-395, blaOXA-847
    Croatia blaVIM-2, blaOXA-10, blaVIM-1, blaVIM-2, blaPER-1, blaGES-7
    Albania blaNDM-1, blaOXA-488, blaPAO
    E. coli Hungary blaCTX-M-1, blaOXA-1, blaCTX-M-15, blaOXA-181, blaCTX-M-32, blaSHV-2, blaTEM-1, blaVIM-4, blaSHV-5, blaSHV-12, blaDHA-1, blaCMY-2, blaCMY-4, blaCMY-16, blaNDM-1, blaNDM-5, blaCTX-M-24, blaOXA-9, blaOXA-10, blaCARB-12
    Serbia blaCTX-M-1, blaCMY-2, blaNDM-1, blaOXA-1, blaSHV-12, blaTEM-1, blaOXA-10, blaOXA-48
    Croatia blaCTX-M-27, blaTEM-1, blaOXA-1, blaOXA-48, blaCTX-M-1, blaCTX-M-15/blaTEM-116, blaCTX-M-15, blaCTX-M-55, blaKPC-2
    Bosnia and Herzegovina blaCTX-M-1, blaCTX-M-3, blaCTX-M-15, blaSHV-1, blaSHV-5, blaCMY-2
    A. baumannii Hungary blaPER-1, blaOXA-23, blaOXA-72
    Serbia blaOXA-72, blaOXA-66, blaADC-25, blaOXA-23, blaADC-73, blaADC-217, blaNDM-1, blaADC-30, blaADC-74
    Croatia blaOXA-23, blaOXA-66, blaADC-25, blaOXA-40-like, blaOXA-51-like, blaOXA-72
    Albania blaTEM-1, blaOXA-23, blaOXA-51
    Bosnia and Herzegovina blaOXA-23-like, blaOXA-40-like, blaOXA-51-like, blaOXA-69, blaOXA-72, blaADC

     | Show Table
    DownLoad: CSV

    A flowchart summarizing possible sample collection and analysis steps for molecular microbiological studies based on a One Health approach is provided in Figure 2. Some potential measures that can be considered to reduce the emergence and dissemination of antimicrobial resistance between the three One Health domains may include implementing or improving the sewage systems and wastewater treatment plants, reducing the amount of antibiotics consumed by humans and animals through market regulation, favoring more labile antibiotics, controlling pharmaceutical effluents, reducing the veterinary use of antibiotics, improving hygiene, and regulating the use of antibiotics, according to the proposal of Martak and colleagues [88].

    It has been disclosed that the average Global One Health Index - Antimicrobial Resistance (GOHI-AMR) score for 146 nations is 39.85 [90]. A publication by Lancet in 2024 estimated that bacterial AMR was responsible for 4.71 million (95% uncertainty intervals 4.23–5.19) deaths in 2021, including 1.14 million (1.00–1.28) deaths attributable to bacterial AMR. The AMR burden is expected to rise to 1.91 million attributable deaths and 8.22 million associated deaths in 2050, with sub-Saharan Africa and south Asia bearing the brunt of this increase in absolute numbers [91].

    Figure 2.  A graphical presentation on screening for antibiotic resistant bacteria in the Agribiotechnology and Precision Breeding for Food Security National Laboratory in Hungary [64],[65],[67],[87],[89].

    The Western Balkans region together with their neighboring EU countries face significant challenges in addressing the growing issue of bacterial multidrug resistance. To combat this threat, it is essential to adopt a multifaceted approach that includes improving antibiotic stewardship, enhancing infection control measures, strengthening surveillance and monitoring, investing in research and development, and fostering regional collaborations. Consequently, it is also advised that a One Health approach shall be considered and followed during such efforts, which is similar to the principles of the Agribiotechnology and Precision Breeding for Food Security National Laboratory in Hungary for the screening protocols of antibiotic-resistant bacteria. Further research is needed to discover novel antimicrobial agents and alternative antimicrobial treatments and regional collaborations should be fostered to address the global threat of multidrug-resistant pathogens.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.


    Acknowledgments



    The preparation of this review article was supported by the Hungarian National Research, Development and Innovation Office, and by the Stipendium Hungaricum-Tempus Public Foundation scholarship programme. The first author (C.L.O) is grateful for the financial support provided during this PhD project, which facilitated the completion of this work. C.L.O is also a public-health advocate and founder of Healthy Environment and Lifestyles Initiative (Delta State, Nigeria).

    Conflict of interest



    The authors declare no competing interests.

    Author contributions



    Conceptualization, C.L.O., and B.L.; Methodology, C.L.O., and B.L.; Supervision, B.L, K. P. and F.O.; Formal analysis and investigation, C.L.O., B.L. and F.O.; Writing-original draft preparation, C.L.O., and B.L.; Writing, review and editing, C.L.O., K.P., B.L. and F.O.; Funding acquisition, K.P. and F.O. All authors have read and agreed to the published version of the manuscript.

    Funding



    This research was funded by the Hungarian National Research, Development and Innovation Office OTKA, grant number NKFI K 132687 (F.O.); the Hungarian National Research, Development and Innovation Office project “Antibiotic and zinc oxide-free feeding during the piglet rearing phase” with the grant number GINOP_PLUSZ-2.1.1-21-2022-00221 (F. O.); and by the Hungarian National Laboratory Project, grant number RRF-2.3.1-21-2022-00007 (K.P.). C.L.O. was supported by the Tempus Public Foundation/Stipendium Hungaricum, identity number 2023_675297 of the Hungarian University of Agriculture and Life Sciences, Doctoral School of Biological Sciences, Gödöllő, Hungary.

    [1] Breijyeh Z, Jubeh B, Karaman R (2020) Resistance of Gram-Negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 25: 1340. https://doi.org/10.3390/molecules25061340
    [2] WHO Regional Office for Europe/European Centre for Disease Prevention and ControlAntimicrobial resistance surveillance in Europe 2022–2020 data (2022). Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data
    [3] Central Asian and European surveillance of antimicrobial resistance: Annual report 2019. Available from: https://www.who.int/europe/groups/central-asian-and-european-surveillance-of-antimicrobial-resistance-(caesar)
    [4] Bharadwaj A, Rastogi A, Pandey S, et al. (2022) Multidrug-resistant bacteria: Their mechanism of action and prophylaxis. Biomed Res Int 2022: 5419874. https://doi.org/10.1155/2022/5419874
    [5] Abduzaimovic A, Aljicevic M, Rebic V, et al. (2016) Antibiotic resistance in urinary isolates of Escherichia coli. Mater Sociomed 28: 416-419. https://doi.org/10.5455/msm.2016.28.416-419
    [6] Kot B (2019) Antibiotic resistance among uropathogenic Escherichia coli. Pol J Microbiol 68: 403-415. https://doi.org/10.33073/pjm-2019-048
    [7] Libisch B (2013) Molecular typing methods for the genus Pseudomonas. Molecular Typing in Bacterial Infections . Totowa: Humana Press 407-429. https://doi.org/10.1007/978-1-62703-185-1_24
    [8] Radovanovic RS, Savic NR, Ranin L, et al. (2020) Biofilm production and antimicrobial resistance of clinical and food isolates of Pseudomonas spp. Curr Microbiol 77: 4045-4052. https://doi.org/10.1007/s00284-020-02236-4
    [9] Schwartz T, Volkmann H, Kirchen S, et al. (2006) Real-time PCR detection of Pseudomonas aeruginosa in clinical and municipal wastewater and genotyping of the ciprofloxacin-resistant isolates. FEMS Microbiol Ecol 57: 158-167. https://doi.org/10.1111/j.1574-6941.2006.00100.x
    [10] European Centre for Disease Prevention and Control and World Health OrganizationAntimicrobial resistance surveillance in Europe 2023–2021 data (2023). Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023-2021-data
    [11] Manyi-Loh C, Mamphweli S, Meyer E, et al. (2018) Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules 23: 795. https://doi.org/10.3390/molecules23040795
    [12] Garcia-Alvarez L, Dawson S, Cookson B, et al. (2012) Working across the veterinary and human health sectors. J Antimicrob Chemother 67: i37-i49. https://doi.org/10.1093/jac/dks206
    [13] Regulation (EU) 2019/6 of the European parliament and of the council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance). OJEU 43-167. Available from: http://data.europa.eu/eli/reg/2019/6/oj
    [14] U.S. Food and Drug AdministrationAntimicrobial Resistance (2025). Available from: https://www.fda.gov/animal-veterinary/safety-health/antimicrobial-resistance
    [15] Roth N, Käsbohrer A, Mayrhofer S, et al. (2019) The application of antibiotics in broiler production and the resulting antibiotic resistance in Escherichia coli: A global overview. Poult Sci 98: 1791-804. https://doi.org/10.3382/ps/pey539
    [16] Xu C, Kong L, Gao H, et al. (2022) A review of current bacterial resistance to antibiotics in food animals. Front Microbiol 13: 822689. https://doi.org/10.3389/fmicb.2022.822689
    [17] Larsson DGJ, Flach CF (2022) Antibiotic resistance in the environment. Nat Rev Microbiol 20: 257-269. https://doi.org/10.1038/s41579-021-00649-x
    [18] de Lorenzo Gilsanz FJ, Flores Martos R, Mora Rosado S (2025) Unpacking vulnerability among migrant minors in the EU: A case study of vulnerability among migrant minors in Spain. Int J Soc Welf 34: e12717. https://doi.org/10.1111/ijsw.12717
    [19] Berishaj V, Schwadere G, Arning A, et al. (2024) Biodiversity. The case of the Western Balkans, Europe: EuroNatur Foundation. Available from: https://www.euronatur.org/fileadmin/docs/umweltpolitik/Biodiversitaet/EuroNatur_Biodiversity_Report_211124.pdf.
    [20] Foti M, Mascetti A, Fisichella V, et al. (2017) Antibiotic resistance assessment in bacteria isolated in migratory Passeriformes transiting through the Metaponto territory (Basilicata, Italy). Avian Res 8: 26. https://doi.org/10.1186/s40657-017-0085-2
    [21] Elsohaby I, Samy A, Elmoslemany A, et al. (2021) Migratory wild birds as a potential disseminator of antimicrobial-resistant bacteria around Al-Asfar Lake, Eastern Saudi Arabia. Antibiotics 10: 260. https://doi.org/10.3390/antibiotics10030260
    [22] Rahman A, Chowdhury Md.SR, Hossain H, et al. (2024) Identification of virulence genes and multidrug resistance in Shiga-toxin producing Escherichia coli (STEC) from migratory and captive wild birds. Pak Vet J 44: 1120-1130. http://dx.doi.org/10.29261/pakvetj/2024.264
    [23] Magiorakos AP, Srinivasan A, Carey RB, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
    [24] Centers for Disease Control and Prevention (U.S.), National Center for Emerging Zoonotic and Infectious Diseases (U.S.), Division of Healthcare Quality Promotion, and Antibiotic Resistance Coordination and Strategy UnitAntibiotic resistance threats in the United States, 2019 (2019). http://dx.doi.org/10.15620/cdc:82532
    [25] Tsanova D (2020) The Balkan countries in global burden of diseases studies. Arch Balk Medical Union 55: 684-690. https://doi.org/10.31688/ABMU.2020.55.4.16
    [26] Peykov S, Strateva T (2023) Whole-Genome Sequencing-Based resistome analysis of nosocomial multidrug-resistant non-fermenting Gram-Negative pathogens from the Balkans. Microorganisms 11: 651. https://doi.org/10.3390/microorganisms11030651
    [27] Jonas OB, Irwin A, Berthe FCJ, et al. Drug-resistant infections: A threat to our economic future (Vol. 2): FInal report (English) (2017). Available from: http://documents.worldbank.org/curated/en/323311493396993758/final-report.
    [28] Lepsanovic Z, Libisch B, Tomanovic B, et al. (2008) Characterisation of the first VIM metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia. Acta Microbiol Immunol Hung 55: 447-454. https://doi.org/10.1556/AMicr.55.2008.4.9
    [29] Libisch B, Poirel L, Lepsanovic Z, et al. (2008) Identification of PER-1 extended-spectrum β-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMSIM 54: 330-338. https://doi.org/10.1111/j.1574-695X.2008.00483.x
    [30] Jovcic B, Lepsanovic Z, Suljagic V, et al. (2011) Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother 55: 3929-3931. https://doi.org/10.1128/AAC.00226-11
    [31] Jovčić B, Lepšanović Z, Begović J, et al. (2014) Two copies of blaNDM-1 gene are present in NDM-1 producing Pseudomonas aeruginosa isolates from Serbia. Antonie Van Leeuwenhoek 105: 613-618. https://doi.org/10.1007/s10482-013-0094-z
    [32] Kabic J, Fortunato G, Vaz-Moreira I, et al. (2023) Dissemination of metallo-β-lactamase-producing Pseudomonas aeruginosa in Serbian hospital settings: Expansion of ST235 and ST654 clones. Int J Mol Sci 24: 1519. https://doi.org/10.3390/ijms24021519
    [33] Kabic J, Novovic K, Kekic D, et al. (2022) Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii. Comput Struct Biotechnol J 21: 574-585. https://doi.org/10.1016/j.csbj.2022.12.045
    [34] Tafaj S, Gona F, Rodrigues CF, et al. (2020) Whole-Genome Sequences of two NDM-1-Producing Pseudomonas aeruginosa strains isolated in a clinical setting in Albania in 2018. Microbiol Resour Announc 9. https://doi.org/10.1128/MRA.01291-19
    [35] Dortet L, Bonnin RA, Bernabeu S, et al. (2016) First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia. Antimicrob Agents Chemother 60: 5724-5730. https://doi.org/10.1128/AAC.01016-16
    [36] Gajic I, Jovicevic M, Milic M, et al. (2021) Clinical and molecular characteristics of OXA-72-producing Acinetobacter baumannii ST636 outbreak at a neonatal intensive care unit in Serbia. J Hosp Infect 112: 54-60. https://doi.org/10.1016/j.jhin.2021.02.023
    [37] Abdelbary MMH, Prod'hom G, Greub G, et al. (2017) Draft genome sequences of two Carbapenemase-Producing Acinetobacter baumannii clinical strains isolated from Albanian and Togolese Patients. Genome Announc 5: e00115-e00117. https://doi.org/10.1128/genomeA.00115-17
    [38] Sardelic S, Bedenic B, Colinon-Dupuich C, et al. (2012) Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob Agents Chemother 56: 2746-2749. https://doi.org/10.1128/AAC.05212-11
    [39] Guzvinec M, Izdebski R, Butic I, et al. (2014) Sequence types 235, 111, and 132 predominate among multidrug-resistant Pseudomonas aeruginosa clinical isolates in Croatia. Antimicrob Agents Chemother 58: 6277-6283. https://doi.org/10.1128/AAC.03116-14
    [40] Krilanović M, Tomić-Paradžik M, Meštrović T, et al. (2020) Extended-spectrum β-lactamases and plasmid diversity in urinary isolates of Escherichia coli in Croatia: a nation-wide, multicentric, retrospective study. Folia Microbiol (Praha) 65: 649-667. https://doi.org/10.1007/s12223-019-00769-1
    [41] Bandić Pavlović D, Pospišil M, Nađ M, et al. (2024) Multidrug-resistant bacteria in surgical intensive care units: Antibiotic susceptibility and β-lactamase characterization. Pathogens 13: 411. https://doi.org/10.3390/pathogens13050411
    [42] D'Onofrio V, Conzemius R, Varda-Brkić D, et al. (2020) Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia. Infect Genet Evol 81: 104263. https://doi.org/10.1016/j.meegid.2020.104263
    [43] Petrović T, Uzunović S, Barišić I, et al. (2018) Arrival of carbapenem-hydrolyzing-oxacillinases in Acinetobacter baumannii in Bosnia and Herzegovina. Infect Genet Evol 58: 192-198. https://doi.org/10.1016/j.meegid.2017.12.021
    [44] Ibrahimagić A, Bedenić B, Kamberović F, et al. (2015) High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC β-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings. J Infect Chemother 21: 363-369. https://doi.org/10.1016/j.jiac.2015.01.003
    [45] Kompes G, Duvnjak S, Reil I, et al. (2023) First report and characterization of the mcr-1 positive multidrug-resistant Escherichia coli strain isolated from pigs in Croatia. Microorganisms 11: 2442. https://doi.org/10.3390/microorganisms11102442
    [46] Maravić A, Skočibušić M, Samanić I, et al. (2012) Antibiotic susceptibility profiles and first report of TEM extended-spectrum β-lactamase in Pseudomonas fluorescens from coastal waters of the Kaštela Bay, Croatia. World J Microbiol Biotechnol 28: 2039-2045. https://doi.org/10.1007/s11274-012-1006-5
    [47] Puljko A, Rozman SD, Barišić I, et al. (2023) Resistance to critically important antibiotics in hospital wastewater from the largest Croatian city. Sci Total Environ 870: 161805. https://doi.org/10.1016/j.scitotenv.2023.161805
    [48] Hrenovic J, Goic-Barisic I, Kazazic S, et al. (2016) Carbapenem-resistant isolates of Acinetobacter baumannii in a municipal wastewater treatment plant, Croatia, 2014. Euro Surveill 21. https://doi.org/10.2807/1560-7917.ES.2016.21.15.30195
    [49] Hrenovic J, Durn G, Music MS, et al. (2017) Extensively and multi drug-resistant Acinetobacter baumannii recovered from technosol at a dump site in Croatia. Sci Total Environ 607–608: 1049-1055. https://doi.org/10.1016/j.scitotenv.2017.07.108
    [50] Higgins PG, Hrenovic J, Seifert H, et al. (2018) Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plant. Water Res 140: 261-267. https://doi.org/10.1016/j.watres.2018.04.057
    [51] Cirkovic I, Muller BH, Janjusevic A, et al. (2023) Whole-Genome sequencing snapshot of clinically relevant Carbapenem-Resistant Gram-Negative bacteria from wastewater in Serbia. Antibiotics 12: 350. https://doi.org/10.3390/antibiotics12020350
    [52] Velhner M, Todorović D, Novović K, et al. (2021) Characterization of antibiotic resistance in Escherichia coli isolates from Black-headed gulls (Larus ridibundus) present in the city of Novi Sad, Serbia. Vet Res Commun 45: 199-209. https://doi.org/10.1007/s11259-021-09801-7
    [53] Libisch B, Muzslay M, Gacs M, et al. (2006) Molecular epidemiology of VIM-4 metallo-β-lactamase-producing Pseudomonas sp. isolates in Hungary. Antimicrob Agents Chemother 50: 4220-4223. https://doi.org/10.1128/AAC.00300-06
    [54] Libisch B, Watine J, Balogh B, et al. (2008) Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res Microbiol 159: 162-168. https://doi.org/10.1016/j.resmic.2007.12.008
    [55] Szabó D, Szentandrássy J, Juhász Z, et al. (2008) Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumannii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary. Ann Clin Microbiol Antimicrob 7: 12. https://doi.org/10.1186/1476-0711-7-12
    [56] Libisch B, Balogh B, Füzi M (2009) Identification of two multidrug-resistant Pseudomonas aeruginosa clonal lineages with a countrywide distribution in Hungary. Curr Microbiol 58: 111-116. https://doi.org/.1007/s00284-008-9285-7
    [57] O'Neall D, Juhász E, Tóth Á, et al. (2020) Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary. Acta Microbiol Immunol Hung 67: 61-65. https://doi.org/10.1556/030.2020.01152
    [58] Szmolka A, Anjum MF, La Ragione RM, et al. (2012) Microarray based comparative genotyping of gentamicin resistant Escherichia coli strains from food animals and humans. Vet Microbiol 156: 110-118. https://doi.org/10.1016/j.vetmic.2011.09.030
    [59] Tóth Á, Juhász-Kaszanyitzky E, Mag T, et al. (2013) Characterization of extended-spectrum β-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006–2007. Acta Microbiol Immunol Hung 60: 175-185. https://doi.org/10.1556/AMicr.60.2013.2.8
    [60] Gulyás D, Kamotsay K, Szabó D, et al. (2023) Investigation of delafloxacin resistance in Multidrug-Resistant Escherichia coli strains and the detection of E. coli ST43 international high-risk clone. Microorganisms 11: 1602. https://doi.org/10.3390/microorganisms11061602
    [61] Nagy JB, Koleszár B, Khayer B, et al. (2023) Carbapenem-resistant Escherichia coli in Black-headed gulls, the Danube, and human clinical samples: A One Health comparison of contemporary isolates. J Glob Antimicrob Resist 35: 257-261. https://doi.org/10.1016/j.jgar.2023.10.002
    [62] Balázs B, Tóth Z, Nagy JB, et al. (2022) Faecal carriage of Carbapenem-Resistant Acinetobacter baumannii: comparison to clinical isolates from the same period (2017–2019). Pathogens 11: 1003. https://doi.org/10.3390/pathogens11091003
    [63] Szmolka A, Lestár B, Pászti J, et al. (2015) Conjugative IncF and IncI1 plasmids with tet(A) and class 1 integron conferring multidrug resistance in F18+ porcine enterotoxigenic E. coli. Acta Vet Hung 63: 425-443. https://doi.org/10.1556/004.2015.040
    [64] Libisch B, Nagy G, Csivincsik A, et al. (2023) Detection of acquired antibiotic resistance determinants in the intestinal microbiota of food producing animals in Hungary. Centre of expertise on antimicrobial consumption and resistance in animals (AMCRA) (Editor) Book of Abstracts, “Antimicrobial resistance: A challenge for public health, animal health and environment” . Belgium: Scientific Symposium Brussels 19-20.
    [65] Libisch B, Abdulkadir S, Papp P, et al. (2022) Detection of acquired antibiotic resistance genes in domestic pig (Sus scrofa) and common carp (Cyprinus carpio) intestinal samples by metagenomics analyses in Hungary. Antibiotics 1441. https://doi.org/10.3390/antibiotics11101441
    [66] Szmolka A, Gellért Á, Szemerits D, et al. (2023) Emergence and Genomic Features of a mcr-1 Escherichia coli from Duck in Hungary. Antibiotics 12: 1519. https://doi.org/10.3390/antibiotics12101519
    [67] Libisch B, Keresztény T, Kerényi Z, et al. (2020) Metagenomic analysis of acquired antibiotic resistance determinants in the gut microbiota of wild boars (Sus Scrofa)-Preliminary Results. J Vet Res 64: 111-118. https://doi.org/10.2478/jvetres-2020-0015
    [68] Hammoudi Halat D, Ayoub Moubareck C (2022) The intriguing carbapenemases of Pseudomonas aeruginosa: Current status, genetic profile, and global epidemiology. Yale J Biol Med 95: 507-515.
    [69] Hadadi-Fishani M, Khaledi A, Fatemi-Nasab ZS (2020) Correlation between biofilm formation and antibiotic resistance in Pseudomonas aeruginosa: A meta-analysis. Infez Med 28: 47-54.
    [70] Qin S, Xiao W, Zhou C, et al. (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Sig Transduct Target Ther 7: 199. https://doi.org/10.1038/s41392-022-01056-1
    [71] Poirel L, Madec J, Lupo A, et al. (2018) Antimicrobial resistance in Escherichia coli. Microbiol Spectr 6. https://doi.org/10.1128/microbiolspec.arba-0026-2017
    [72] Ibrahim S, Al-Saryi N, Al-Kadmy IMS, et al. (2021) Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep 48: 6987-6998. https://doi.org/10.1007/s11033-021-06690-6
    [73] Mukhopadhyay H, Bairagi A, Mukherjee A, et al. (2024) Multidrug resistant Acinetobacter baumannii: A study on its pathogenesis and therapeutics. Cur Res Micro Sci 8: 100331. https://api.semanticscholar.org/CorpusID:274579668
    [74] Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Available from: https://iris.who.int/bitstream/handle/10665/259462/9789241550178-eng.pdf
    [75] Yong D, Toleman MA, Giske CG, et al. (2009) Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. AAC 53: 5046-5054. https://doi.org/10.1128/AAC.00774-09
    [76] Kehl K, Schallenberg A, Szekat C, et al. (2022) Dissemination of carbapenem resistant bacteria from hospital wastewater into the environment. Sci Total Environ 806: 151339. https://doi.org/10.1016/j.scitotenv.2021.151339
    [77] Zagui GS, Gonçalves de Almeida OG, Moreira NC (2024) Hospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11. Environ Res 255: 119166. https://doi.org/10.1016/j.envres.2024.119166
    [78] Jangsangthong A, Lugsomya K, Apiratwarrasakul S, et al. (2024) Distribution of sequence types and antimicrobial resistance of clinical Pseudomonas aeruginosa isolates from dogs and cats visiting a veterinary teaching hospital in Thailand. BMC Vet Res 20: 234. https://doi.org/10.1186/s12917-024-04098-5
    [79] Hayashi W, Izumi K, Yoshida S, et al. (2021) Antimicrobial resistance and Type III secretion system virulotypes of Pseudomonas aeruginosa isolates from dogs and cats in Primary Veterinary Hospitals in Japan: Identification of the international high-risk clone sequence type 235. Microbiol Spectr 9. https://doi.org/10.1128/Spectrum.00408-21
    [80] Soliman AM, Nariya H, Tanaka D, et al. (2021) Vegetable-derived carbapenemase-producing high-risk Klebsiella pneumoniae ST15 and Acinetobacter baumannii ST2 clones in Japan: Coexistence of blaNDM-1, blaOXA-66, blaOXA-72, and an AbaR4-Like resistance island in the same sample. Appl Environ Microbiol 8. https://doi.org/10.1128/AEM.02166-20
    [81] Taj Z, Rasool MH, Almatroudi A, et al. (2020) Extensively Drug-resistant Acinetobacter baumannii belonging to international clone II from a pet cat with urinary tract Infection; The first report from Pakistan. Pol J Microbiol 69: 1-4. https://doi.org/10.33073/pjm-2020-017
    [82] Mshana SE, Imirzalioglu C, Hain T, et al. (2011) Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin Microbiol Infect 17: 1279-1282. https://doi.org/10.1111/j.1469-0691.2011.03518.x
    [83] Jouini A, Klibi A, Elarbi I, et al. (2021) First detection of human ST131-CTX-M-15-O25-B2 Clone and High-Risk clonal lineages of ESBL/pAmpC-Producing E. coli isolates from diarrheic poultry in Tunisia. Antibiotics 10: 670. https://doi.org/10.3390/antibiotics10060670
    [84] Hernandez J, Bonnedahl J, Eliasson I, et al. (2010) Globally disseminated human pathogenic Escherichia coli of O25b-ST131 clone, harbouring blaCTX-M-15, found in Glaucous-winged gull at remote Commander Islands, Russia. Environ Microbiol Rep 2: 329-332. https://doi.org/10.1111/j.1758-2229.2010.00142.x
    [85] Pandey S, Doo H, Keum GB, et al. (2023) Antibiotic resistance in livestock, environment and humans: One Health perspective. Anim Sci Technol 66: 266-278. https://doi.org/10.5187/jast.2023.e129
    [86] Libisch B (2024) N-Alkane Assimilation by Pseudomonas aeruginosa and its interactions with virulence and antibiotic resistance. Antibiotics 13: 1028. https://doi.org/10.3390/antibiotics13111028
    [87] Libisch B, Picot C, Ceballos-Garzon A, et al. (2022) Prototheca infections and ecology from a One Health perspective. Microorganisms 10: 938. https://doi.org/10.3390/microorganisms10050938
    [88] Martak D, Henriot CP, Didier Hocquet D (2024) Environment, animals, and food as reservoirs of antibiotic-resistant bacteria for humans: One health or more?. Infectious Diseases Now 54: 104895. https://doi.org/10.1016/j.idnow.2024.104895
    [89] Ozoaduche CL, Libisch B, Itoro D, et al. (2025) Antibiotic resistance and virulence determinants of Pseudomonas aeruginosa isolates cultured from Hydrocarbon-Contaminated environmental samples. Microorganisms 13: 688. https://doi.org/10.3390/microorganisms13030688
    [90] Zhou N, Cheng Z, Zhang X, et al. (2022) Global antimicrobial resistance: A system-wide comprehensive investigation using the Global One Health Index. Infect Dis Poverty 11: 92. https://doi.org/10.1186/s40249-022-01016-5
    [91] GBD 2021 Antimicrobial Resistance Collaborators.Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. Lancet (2024) 404: 1199-1226. https://doi.org/10.1016/S0140-6736(24)01867-1
  • microbiol-11-02-020-s001.xlsx
  • Reader Comments
  • © 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(313) PDF downloads(52) Cited by(0)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog